The new €3.2M (US$3.7M) research lab will investigate immunogenic cell death mechanisms in lung cancer to improve how existing therapies trigger immune response.

The global cell and gene therapy market is forecast to surge from $10.4 billion to more than $45 billion by 2035, with over 40 FDA-approved products and North America commandi ...

Lawyers are scheduled to make closing arguments at the trial of a Utah woman who published a children’s book about grief ...

In Japanese, the word “shinobi” evokes the ninja — blending into the background, unseen. Today, that same idea is inspiring a breakthrough in regenerative medicine.

A DR5-mediated apoptotic strategy combined with irinotecan/temozolomide achieved a 64.5% ORR and 87.1% DCR in ...

The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...

TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...

Newsweek has broken down how Iran could hypothetically attack California.

The Justice Department is attempting to open criminal investigations into Colombian President Gustavo Petro—one of the Americas’ most outspoken opponents of President Donald Trump, as well as Israel’s ...